Ser60
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.0.1
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser60  -  STMN3 (human)

Site Information
sFEVILksPSDLsPE   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 4698871

In vivo Characterization
Methods used to characterize site in vivo:
[32P] ATP in vitro ( 2 ) , immunoassay ( 2 ) , mutation of modification site ( 2 ) , phospho-antibody ( 2 ) , western blotting ( 2 )
Relevant cell line - cell type - tissue:
HeLa (cervical) ( 2 ) , neuron-'brain, hippocampus' ( 2 )

Upstream Regulation
Putative in vivo kinases:
GSK3B (human) ( 2 )
Kinases, in vitro:
GSK3A (human) ( 2 ) , JNK1 (human) ( 1 )
Treatments:
AR-A014418 ( 2 ) , GSK-3_inhibitor_XV ( 2 )

Downstream Regulation
Effects of modification on STMN3:
intracellular localization ( 2 )
Effects of modification on biological processes:
cytoskeletal reorganization ( 2 )

References 

1

Yip YY, Yeap YY, Bogoyevitch MA, Ng DC (2014) Differences in c-Jun N-terminal kinase recognition and phosphorylation of closely related stathmin-family members. Biochem Biophys Res Commun 446, 248-54
24589734   Curated Info

2

Devaux S, et al. (2012) Specific Serine-Proline Phosphorylation and Glycogen Synthase Kinase 3β-directed Subcellular Targeting of Stathmin 3/Sclip in Neurons. J Biol Chem 287, 22341-53
22577147   Curated Info